Prognostic Measures in Ambulatory Care Settings

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

1998-01-31

Study Completion Date

1999-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this prospective study is to develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity (including the deterioration of pre-existing conditions or development of new problems) and functional deterioration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Specifically, from a random sample of 2000 patients taken from a cohort of established patients followed for at least three years in a general medicine practice, the objectives are:

1. to identify the demographic, clinical, and functional status variable that predict the risk of death, morbid events (e.g., the development of new complications or deterioration of existing conditions), or the deterioration in functional status using a half of the cohort chosen at random;
2. to combine these findings into a prognostic scale that can be employed in routine clinical practice; and
3. to validate the performance of this scale in the second half of the cohort.

There are no interventions in this study. Patients already under medical care by Cornell physicians will be enrolled. The only requirements for patients are to complete the questionnaires on an annual basis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Internal Medicine Patients

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

prognosis risk of death morbidity mortality quality of life

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

There are no interventions in this study

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Patients who are currently under the care of Physicians at Cornell Internal Medicine Associates.

Exclusion Criteria

1. Patients who do not wish to participate in the study.
2. Patients who are not able to provide informed written consent.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Weill Cornell Medical College

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mary E Charlson, MD

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College at Cornell University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New York Presbyterian Hospital-Weill Cornell Medical College

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0397-727

Identifier Type: -

Identifier Source: org_study_id